Markets:

Overview

News

Currencies

International

Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

8.985 -0.075 (-0.83%)

Streaming Delayed Price Updated: 3:02 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Intellia Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness ↗

June 10, 2024

On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). This decision came amidst a period of market fluctuations and followed a...

Via Benzinga

Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought ↗

June 09, 2024

These companies could generate explosive growth over time.

Via The Motley Fool

These 2 Words Are Why Intellia Therapeutics Could Be a Smart Buy Right Now ↗

June 08, 2024

Neither word has anything to do with money -- at least not yet.

Via The Motley Fool

Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock ↗

June 06, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Intellia Therapeutics ↗

June 04, 2024

Via Benzinga

Why Intellia Therapeutics, Inc. Outpaced the Stock Market ↗

May 05, 2024

Investors will be eagerly watching for the performance of Intellia Therapeutics, Inc. in its upcoming earnings disclosure.

Via Talk Markets

2 Stocks Down 30% to Buy Right Now ↗

April 14, 2024

These stocks have plenty of catalysts ahead.

Via The Motley Fool

Is Intellia Therapeutics Stock a Buy Now? ↗

March 09, 2024

The company's future will depend on its innovative qualities.

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

June 06, 2024

The widely followed growth investor made big moves as May came to a close.

Via The Motley Fool

The 3 Best Biotech Stocks to Buy in June 2024 ↗

June 05, 2024

Explore the best biotech stocks to buy in June 2024, with insights on Protagonist, BridgeBio and Intellia.

Via InvestorPlace

Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You? ↗

June 04, 2024

In keeping with Cathie Wood's style, these picks are riskier than average.

Via The Motley Fool

Why Intellia Therapeutics Shares Are Trading Higher Monday ↗

June 03, 2024

Intellia's NTLA-2002 is an experimental CRISPR based gene-editing therapy being developed as a one-time treatment for hereditary angioedema (HAE). The company announced the single does treatment led to...

Via Benzinga

Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday ↗

June 03, 2024

Via Benzinga

Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action ↗

May 30, 2024

On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its portfolio, including a significant sell-off of Robinhood Markets Inc (NASDAQ:HOOD) shares.

Via Benzinga

Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF ↗

May 28, 2024

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings.

Via Benzinga

Topics ETFs

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

May 22, 2024

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

May 10, 2024

Via The Motley Fool

NTLA Stock Earnings: Intellia Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

NTLA stock results show that Intellia Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Just Say No to Drugs: 3 Pharma Stocks to Avoid ↗

May 08, 2024

Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios.

Via InvestorPlace

Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar ↗

May 03, 2024

The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines.

Via InvestorPlace

3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire ↗

May 02, 2024

Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion.

Via InvestorPlace

Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week. ↗

April 12, 2024

These two stocks could be ripe for a rebound.

Via The Motley Fool

Bull Market and Beyond: 3 Stocks Just Waiting to Soar ↗

April 09, 2024

These stocks, a bargain today, are players to hold on to for the long term.

Via The Motley Fool

Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm

April 02, 2024

--News Direct--

Via News Direct

ARKK’s Tech Bets: Over 500k Roblox Shares Purchased, 1.24M Robinhood Shares Sold ↗

March 29, 2024

Cathie Wood's ARK Innovation ETF had an active trading week, with notable transactions including the purchase of over 500k Roblox shares and the sale of 1.247 million shares of Robinhood Markets.

Via Talk Markets

Topics ETFs

Better Cathie Wood Stock: Moderna vs. Intellia ↗

March 28, 2024

Moderna and Intellia have declined in the double digits over the past year.

Via The Motley Fool

Hot Stocks: The 3 Best Opportunities for Investing in Biotech ↗

March 21, 2024

Biotech stocks can offer some of the best risk vs. reward payoff in the stock market. These three are ones to buy now.

Via InvestorPlace

3 Stocks That Could Be the Next Big Thing in Gene Editing ↗

March 21, 2024

Gene editing could revolutionize how millions of patients are treated. That could create big opportunities for gene-editing stocks.

Via InvestorPlace

Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst ↗

March 06, 2024

2024 could see the start of its first late-stage clinical trials.

Via The Motley Fool

A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now ↗

February 29, 2024

The futures for these two beaten-down stocks could be brighter than their recent pasts.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.